{"id":"W4379282038","doi":"10.1200/jco.2023.41.16_suppl.8039","title":"Elranatamab, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, for patients (pts) with relapsed/refractory multiple myeloma (RRMM): Extended follow up and biweekly administration from the MagnetisMM-3 study.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"Pfizer","keywords":"Medicine; Internal medicine; Discontinuation; Refractory (planetary science); Adverse effect; Gastroenterology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001428372,0.0005530039,0.0007534178,0.0002519776,0.0003410622,0.0005236614,0.0004891824,0.0004779279,0.00210089],"category_scores_gemma":[0.0004204662,0.0002427484,0.0006021985,0.0003585365,0.0003045097,0.0004032284,0.0003246366,0.001118814,0.0004568436],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007653791,"about_ca_system_score_gemma":0.0009067359,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008826513,"about_ca_topic_score_gemma":0.003363991,"domain_scores_codex":[0.9997104,0.0001361412,0.00001816923,0.00004699958,0.000040945,0.00004736178],"domain_scores_gemma":[0.9996451,0.00004776756,0.0001054192,0.00002733623,0.00001593968,0.0001583635],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4815872,0.02066787,0.1925116,0.0008678747,0.00240588,0.0008751487,0.0003541405,0.00230538,0.06487445,0.0002434941,0.007772068,0.2255349],"study_design_scores_gemma":[0.2530974,0.269128,0.4479427,0.0001112307,0.002242215,0.001772079,0.0001164022,0.002739618,0.008308481,0.0003438603,0.014151,0.00004701217],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948232,0.001806722,0.0003057583,0.0002152828,0.00002407894,0.0005921807,0.001228861,0.0000321246,0.0009718988],"genre_scores_gemma":[0.9940593,0.0008414694,0.0006737398,0.0004044203,0.00007392019,0.0004718027,0.002547724,0.00000971296,0.0009179487],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00210089,"threshold_uncertainty_score":0.007553995,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09237953159947176,"score_gpt":0.4317053603468726,"score_spread":0.3393258287474009,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}